Muscarinic Acetylcholine Receptors in the Retina—Therapeutic Implications
Open Access
- 8 May 2021
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (9), 4989
- https://doi.org/10.3390/ijms22094989
Abstract
Muscarinic acetylcholine receptors (mAChRs) belong to the superfamily of G-protein-coupled receptors (GPCRs). The family of mAChRs is composed of five subtypes, M1, M2, M3, M4 and M5, which have distinct expression patterns and functions. In the eye and its adnexa, mAChRs are widely expressed and exert multiple functions, such as modulation of tear secretion, regulation of pupil size, modulation of intraocular pressure, participation in cell-to-cell signaling and modula-tion of vascular diameter in the retina. Due to this variety of functions, it is reasonable to assume that abnormalities in mAChR signaling may contribute to the development of various ocular diseases. On the other hand, mAChRs may offer an attractive therapeutic target to treat ocular diseases. Thus far, non-subtype-selective mAChR ligands have been used in ophthalmology to treat dry eye disease, myopia and glaucoma. However, these drugs were shown to cause various side-effects. Thus, the use of subtype-selective ligands would be useful to circumvent this problem. In this review, we give an overview on the localization and on the functional role of mAChR subtypes in the eye and its adnexa with a special focus on the retina. Moreover, we describe the pathophysiological role of mAChRs in retinal diseases and discuss potential therapeutic approaches.This publication has 127 references indexed in Scilit:
- Muscarinic cholinergic receptor (M2) plays a crucial role in the development of myopia in miceDisease Models & Mechanisms, 2013
- Muscarinic Acetylcholine Receptor Subtypes as Potential Drug Targets for the Treatment of Schizophrenia, Drug Abuse, and Parkinson’s DiseaseACS Chemical Neuroscience, 2011
- Identification of the Muscarinic Acetylcholine Receptor Subtype Mediating Cholinergic Vasodilation in Murine Retinal ArteriolesInvestigative Ophthalmology & Visual Science, 2011
- Muscarinic Acetylcholine Receptor Localization and Activation Effects on Ganglion Response PropertiesInvestigative Ophthalmology & Visual Science, 2010
- Cholinergic Activation of M2 Receptors Leads to Context-Dependent Modulation of Feedforward Inhibition in the Visual ThalamusPLoS Biology, 2010
- Structural and functional neuroprotection in glaucoma: role of galantamine-mediated activation of muscarinic acetylcholine receptorsCell Death & Disease, 2010
- Subtype-selective allosteric modulators of muscarinic receptors for the treatment of CNS disordersTrends in Pharmacological Sciences, 2009
- Nicotinic Acetylcholine Receptor Subunits in Rhesus Monkey RetinaInvestigative Ophthalmology & Visual Science, 2009
- Acetylcholine beyond neurons: the non‐neuronal cholinergic system in humansBritish Journal of Pharmacology, 2008
- Muscarinic Receptor Agonists and AntagonistsMolecules, 2001